John C Marshall
John C Marshall
Professor of Surgery, University of Toronto
Verified email at
Cited by
Cited by
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012
RP Dellinger, MM Levy, A Rhodes, D Annane, H Gerlach, SM Opal, ...
Intensive care medicine 39 (2), 165-228, 2013
The third international consensus definitions for sepsis and septic shock (Sepsis-3)
M Singer, CS Deutschman, CW Seymour, M Shankar-Hari, D Annane, ...
Jama 315 (8), 801-810, 2016
MM Levy
Crit Care Med 31, 1250-1256, 2003
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016
A Rhodes, LE Evans, W Alhazzani, MM Levy, M Antonelli, R Ferrer, ...
Intensive care medicine 43 (3), 304-377, 2017
Definitions for sepsis and organ afilure and guidelines for the use of innovative therapies in sepsis.
American College of Chest Physicians
Crit care med 20, 864-874, 1992
A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care
PC Hébert, G Wells, MA Blajchman, J Marshall, C Martin, G Pagliarello, ...
New England Journal of Medicine 340 (6), 409-417, 1999
Intensive versus conventional glucose control in critically ill patients.
RJJ NICE-SUGAR Study Investigators, Finfer S, Chittock DR, Su SY, Blair D ...
New England Journal of Medicine 360 (13), 1283-1297, 2009
Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome
JC Marshall, DJ Cook, NV Christou, GR Bernard, CL Sprung, WJ Sibbald
Critical care medicine 23 (10), 1638-1652, 1995
International study of the prevalence and outcomes of infection in intensive care units
JL Vincent, J Rello, J Marshall, E Silva, A Anzueto, CD Martin, R Moreno, ...
Jama 302 (21), 2323-2329, 2009
The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis
MM Levy, RP Dellinger, SR Townsend, WT Linde-Zwirble, JC Marshall, ...
Intensive care medicine 36 (2), 222-231, 2010
Critically ill patients with 2009 influenza A (H1N1) infection in Canada
A Kumar, R Zarychanski, R Pinto, DJ Cook, J Marshall, J Lacroix, T Stelfox, ...
Jama 302 (17), 1872-1879, 2009
No surgical innovation without evaluation: the IDEAL recommendations
P McCulloch, DG Altman, WB Campbell, DR Flum, P Glasziou, ...
The Lancet 374 (9695), 1105-1112, 2009
Multiple-organ-failure syndrome
CJ Carrico, JL Meakins, JC Marshall, D Fry, RV Maier
Archives of Surgery 121 (2), 196-208, 1986
Risk factors for gastrointestinal bleeding in critically ill patients
DJ Cook, HD Fuller, GH Guyatt, JC Marshall, D Leasa, R Hall, TL Winton, ...
New England journal of medicine 330 (6), 377-381, 1994
Drotrecogin alfa (activated) in adults with septic shock
VM Ranieri, BT Thompson, PS Barie, JF Dhainaut, IS Douglas, S Finfer, ...
New England Journal of Medicine 366 (22), 2055-2064, 2012
Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome: results from a randomized, double-blind, placebo-controlled trial
CJ Fisher, JFA Dhainaut, SM Opal, JP Pribble, RA Balk, GJ Slotman, ...
Jama 271 (23), 1836-1843, 1994
A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation
D Cook, G Guyatt, J Marshall, D Leasa, H Fuller, R Hall, S Peters, ...
New England Journal of Medicine 338 (12), 791-797, 1998
Safety of Cell Therapy with Mesenchymal Stromal Cells (SafeCell): A Systematic Review and Meta-Analysis of Clinical Trials
MM Lalu, L McIntyre, C Pugliese, D Fergusson, BW Winston, JC Marshall, ...
PloS one 7 (10), e47559, 2012
Assessment of the worldwide burden of critical illness: the intensive care over nations (ICON) audit
JL Vincent, JC Marshall, SA Ñamendys-Silva, B François, ...
The lancet Respiratory medicine 2 (5), 380-386, 2014
Sepsis definitions: time for change
JL Vincent, SM Opal, JC Marshall, KJ Tracey
Lancet (London, England) 381 (9868), 774, 2013
The system can't perform the operation now. Try again later.
Articles 1–20